Agalsidase beta is a recombinant human alpha-galactosidase A enzyme approved for intravenous use in the treatment of Fabry disease.
No products were found matching your selection.
Agalsidase beta is a recombinant human alpha-galactosidase A enzyme approved for intravenous use in the treatment of Fabry disease.